FOLVENGAARD AQUA AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: DH
Dag Hjelle1959
Chairman of the board: JH
Jørund Hagen1966
Years since formation: 1 year; since Jan 4, 2024
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 100; 1 share class
Total number of shareholders: 2; companies
Belongs to group of

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
DH Dag Hjelle 1959	Managing Director/CEO	48 % indirectly

Board

Name	Role	Shares
JH Jørund Hagen 1966	Chairman	1.2 % indirectly
DH Dag Hjelle 1959	Board Member	48 % indirectly
SJ Stig Jarle Rødseth 1955	Board Member	-

Top 10 individual shareholders

Name	Role	Shares
DH Dag Hjelle 1959	Managing Director/CEO, Board Member	48 % indirectly
RO Rolf Olav Reitan Gjørven 1991	-	16 % indirectly
AE Alf Erik Gjørven 1999	-	16 % indirectly
FH Frode Håkon Kjølås 1969	-	3.6 % indirectly
JJ Jan-Emil Johannessen 1960	-	1.28 % indirectly
JH Jørund Hagen 1966	Chairman	1.2 % indirectly

Last update: Jan 4, 2024

Ownership

Company shareholders

Name	Share class	Number of shares	Share
F FOLVENGAARD AS	Ordinary shares	80	80 %
V VITAL SEAFOOD AS	Ordinary shares	20	20 %

Last update: May 24, 2024

Group structure

FOLVENGAARD AS
Total operating income 2023: NOK 2,634,863
Operating profit 2023: NOK -147,468
Employees: 0

Financials

in NOK

No available data

FOLVENGAARD AQUA AS932 763 559